gefitinib has been researched along with chalcone in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (chalcone) | Trials (chalcone) | Recent Studies (post-2010) (chalcone) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 2,015 | 22 | 1,086 |
| Protein | Taxonomy | gefitinib (IC50) | chalcone (IC50) |
|---|---|---|---|
| perilipin-5 | Homo sapiens (human) | 4.245 | |
| perilipin-1 | Homo sapiens (human) | 4.194 | |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | 4.2195 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.41 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 1.41 | |
| Sortase A | Streptococcus mutans | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, JH; Kwon, TK; Oh, YJ; Seo, YH | 1 |
1 other study(ies) available for gefitinib and chalcone
| Article | Year |
|---|---|
Chalcone-templated Hsp90 inhibitors and their effects on gefitinib resistance in non-small cell lung cancer (NSCLC).
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Survival; Chalcone; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gefitinib; HSP90 Heat-Shock Proteins; Humans; Lung Neoplasms; Molecular Docking Simulation; Protein Structure, Secondary; Quinazolines | 2017 |